Swedish Orphan Biovitrum

Últimas notícias

Manchetes no idioma original da fonte.

• 
  Change in number of shares and votes in Sobi (abre em uma nova aba)

  PR Newswire · 30 de set. de 2026

• 
  Sobi to present clinical data on Gamifant® at Histiocyte Society 2026 in Rotterdam (abre em uma nova aba)

  24 de set. de 2026

• Aytu BioPharma, Inc. (AYTU) Reports Q4 Loss, Beats Revenue Estimates (abre em uma nova aba)

  22 de set. de 2026

• 
  Sobi and Innate announce partnership is now effective following completion of closing conditions (abre em uma nova aba)

  17 de set. de 2026

• 
  Sobi Receives US FDA Fast Track Designation for pacritinib in VEXAS Syndrome (abre em uma nova aba)

  GlobeNewswire · 9 de set. de 2026

• Sobi has completed an issue of class C shares (abre em uma nova aba)

  31 de ago. de 2026

• 
  Swedish Orphan Biovitrum (OM:SOBI) Following Its Lacutamab Deal And The Undervalued Narrative (abre em uma nova aba)

  Simply Wall St. · 15 de ago. de 2026

• 
  Swedish Orphan Biovitrum (OM:SOBI) Stock Looks Strong On Returns But Fully Priced On Earnings (abre em uma nova aba)

  Simply Wall St. · 14 de ago. de 2026

• Sobi licenses Innate’s CTCL drug for up to $580m as it heads to Phase III (abre em uma nova aba)

  10 de ago. de 2026

• Sobi enters strategic partnership with Innate Pharma to license lacutamab in T-cell lymphoma (abre em uma nova aba)

  10 de ago. de 2026

• German Covid vaccine pioneer BioNTech chooses new chief executive (abre em uma nova aba)

  3 de ago. de 2026

• 
  BioNTech Announces Appointment of Guido Oelkers to Management Board as Chief Executive Officer (abre em uma nova aba)

  GlobeNewswire · 3 de ago. de 2026

• Guido Oelkers to step down as CEO of Sobi in the beginning of 2027 (abre em uma nova aba)

  3 de ago. de 2026

• Swedish Orphan Biovitrum AB (BIOVF) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and ... (abre em uma nova aba)

  GuruFocus.com · 18 de jul. de 2026

• Sobi Q2 2026 report: Significant growth with important pipeline progress (abre em uma nova aba)

  16 de jul. de 2026

• 
  Assessing Swedish Orphan Biovitrum’s Valuation After A Period Of Building Share Price Momentum (abre em uma nova aba)

  Simply Wall St. · 4 de mai. de 2026

• 
  Altuviiio (Swedish Orphan Biovitrum) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F (abre em uma nova aba)

  GlobeNewswire · 29 de abr. de 2026

• Swedish Orphan Biovitrum AB (BIOVF) Q1 2026 Earnings Call Highlights: Robust Revenue Growth and ... (abre em uma nova aba)

  GuruFocus.com · 29 de abr. de 2026

• 
  Notice of Annual General Meeting in Swedish Orphan Biovitrum AB (publ) (abre em uma nova aba)

  PR Newswire · 27 de mar. de 2026